{"product_id":"ams-hospital-and-internal-medicine-a-clinical-review-of-common-problems-2024","title":"AMS Hospital and Internal Medicine A Clinical Review of Common Problems 2024","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003ch3\u003eAMS Hospital and Internal Medicine A Clinical Review of Common Problems 2024\u003c\/h3\u003e\r\n\u003cstrong\u003e+ Target Audience: hospitalists, internists, family physicians, and allied healthcare providers\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\r\n2024 Hospital and Internal Medicine: A Clinical Review of Common Problems – Fours Day\r\n\r\n\u003cstrong\u003eFaculty: \u003c\/strong\u003eKendal Williams, M.D., M.P.H..; Lawrence H. Brent, M.D.\r\n\r\n\u003cstrong\u003eRelease Date:\u003c\/strong\u003e January 22–25, 2024\r\n\r\nThe \u003cem\u003eAmerican Medical Seminars – Hospital and Internal Medicine: A Clinical Review of Common Problems 2024\u003c\/em\u003e is best for hospitalists, internists, family physicians, and allied healthcare providers who want a concise, update on common inpatient and internal medicine problems. It is particularly valuable for clinicians managing hospitalized patients and those seeking practical, evidence‑based refreshers on everyday conditions.\r\n\u003ch3\u003e Who Should Attend\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eHospitalists \u0026amp; internists managing acute and chronic conditions in inpatient settings.\u003c\/li\u003e\r\n \t\u003cli\u003eFamily physicians \u0026amp; general practitioners who encounter internal medicine problems in outpatient care.\u003c\/li\u003e\r\n \t\u003cli\u003eResidents \u0026amp; fellows in internal medicine or family medicine seeking structured review.\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced practice providers (NPs, PAs) working in hospital or primary care environments.\u003c\/li\u003e\r\n \t\u003cli\u003eAllied health professionals interested in expanding knowledge of common medical problems.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e What You’ll Learn\u003c\/h3\u003e\r\nThe 4‑day program (January 22–25, 2024, Sarasota, Florida) covered:\r\n\u003cul\u003e\r\n \t\u003cli\u003ePulmonary medicine: COPD and asthma management in hospitalized patients.\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious disease: inpatient management of skin and soft tissue infections.\u003c\/li\u003e\r\n \t\u003cli\u003eRheumatology: rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, scleroderma, Raynaud’s disease, idiopathic inflammatory myopathies, spondyloarthropathies.\u003c\/li\u003e\r\n \t\u003cli\u003ePractical updates: diagnostic strategies, treatment protocols, and case‑based learning.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n \r\n\u003ch3\u003e\u003cstrong\u003eDay 1\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cstrong\u003eUpdate on the Management of COPD and Asthma in the Hospitalized Patient\u003c\/strong\u003e\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003e Perform initial management and stabilization of the patient with asthma or COPD exacerbation and distinguish between the strategies for each condition.\u003c\/li\u003e\r\n \t\u003cli\u003e Develop an evidence-based strategy for the management of COPD based on the GOLD criteria.\u003c\/li\u003e\r\n \t\u003cli\u003e Prescribe an effective therapeutic strategy for asthma, taking into account recent studies on the safety and effectiveness of various agents.\u003c\/li\u003e\r\n \t\u003cli\u003e Detect conditions that may mimic asthma or COPD in the clinical setting.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eOverview of the Inpatient Management of Skin and Soft Tissue Infections\u003c\/strong\u003e\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003e Review the clinical presentation and categorization of common skin and soft tissue infections.\u003c\/li\u003e\r\n \t\u003cli\u003e Differentiate common non-infectious conditions that can mimic skin and soft tissue infections.\u003c\/li\u003e\r\n \t\u003cli\u003e Based on evidence from the CDC and standard of care publications, recognize and incorporate the changing epidemiology and resistance patterns impacting skin and soft tissue infections into therapeutic plans.\u003c\/li\u003e\r\n \t\u003cli\u003e Recognize the types of drug-associated rashes and formulate an effective treatment plan for each.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eRheumatoid Arthritis\u003c\/strong\u003e\r\nAttendees of this presentation should be able to:\r\n\r\n• Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.\r\n• Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.\r\n• Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.\r\n• Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines\r\n\r\n\u003cstrong\u003eOsteoarthritis\u003c\/strong\u003e\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003e• Employ the history and physical exam to make an accurate diagnosis of osteoarthritis\u003c\/li\u003e\r\n \t\u003cli\u003e• Differentiate osteoarthritis (structural) from rheumatoid arthritis (inflammatory)\u003c\/li\u003e\r\n \t\u003cli\u003e• Recommend and prescribe non-pharmacologic and pharmacologic therapies for patients with osteoarthritis according the ACR recommendations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eSystemic Lupus Erythematosus\u003c\/strong\u003e\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003e• Evaluate the varied clinical presentations and manifestations in the course of systemic lupus erythematosus.\u003c\/li\u003e\r\n \t\u003cli\u003e• Order and interpret laboratory testing used in the diagnosis of systemic lupus erythematosus in accordance with ACR Guidelines.\u003c\/li\u003e\r\n \t\u003cli\u003e• Monitor and employ treatment options for patients with systemic lupus erythematosus according to EULAR recommendations and evidenced based studies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cstrong\u003eDay 2\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cstrong\u003eScleroderma and Raynaud’s Disease\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eSpecify the clinical manifestations of scleroderma.\u003c\/li\u003e\r\n \t\u003cli\u003eApply the ACR\/EULAR classification criteria for systemic sclerosis.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize treatment available for the manifestations of scleroderma as per the current EULAR recommendations.\u003c\/li\u003e\r\n \t\u003cli\u003eApply an appropriate diagnostic work-up and treatment of Raynaud’s phenomenon.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eIdiopathic Inflammatory Myopathies\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDiagnose idiopathic inflammatory myopathies and differentiate between inflammatory and other types of myopathies\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate patients with drug induced myopathies and other causes of elevated CPK\u003c\/li\u003e\r\n \t\u003cli\u003eRecommend treatment of idiopathic inflammatory myopathies and measure disease activity\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eSpondyloarthropathies\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDistinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.\u003c\/li\u003e\r\n \t\u003cli\u003ePrescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eUpdate on the Evaluation of Chest Pain\u003c\/strong\u003e\r\n\r\nAttendees of this presentation will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eBased on recent standard of care publications, review the contribution of history, physical exam, and EKG findings to the evaluation of chest pain.\u003c\/li\u003e\r\n \t\u003cli\u003eDistinguish ischemic EKG changes from their common mimics.\u003c\/li\u003e\r\n \t\u003cli\u003eApply the use of novel and standard cardiac biomarkers to the diagnosis of ACS.\u003c\/li\u003e\r\n \t\u003cli\u003eBased on the guidance from the ACC\/AHAS and recent significant research studies, determine the best evaluation strategy for the individual chest pain patient.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eUpdate on the Management of Acute Coronary Syndromes\u003c\/strong\u003e\r\n\r\nAttendees of this presentation will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDistinguish the forms of ACS and their relative prognoses.\u003c\/li\u003e\r\n \t\u003cli\u003eBased on the most recent AHA\/ACC guidelines, apply the appropriate initial management of patients experiencing acute coronary syndromes.\u003c\/li\u003e\r\n \t\u003cli\u003eBased on the most recent AHA\/ACC guidelines, categorize the therapeutic options for patients with unstable angina and post-MI.\u003c\/li\u003e\r\n \t\u003cli\u003eBased on the most recent AHA\/ACC guidelines, employ the secondary prevention strategies for\u003c\/li\u003e\r\n \t\u003cli\u003epatients who have experienced an acute coronary syndrome.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cstrong\u003eDay 3\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cstrong\u003eUpdate on the Management of Congestive Heart Failure in the Hospitalized Patient\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eUnderstand and compare the vaccines\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand the recommendations for isolation after exposure and after illness\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand the status of diagnostic tests and treatments\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eUpdate in Inpatient Renal Medicine\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eAttendees of this presentation should be able to:\u003c\/li\u003e\r\n \t\u003cli\u003eReview the evaluation of acute renal failure in the inpatient setting.\u003c\/li\u003e\r\n \t\u003cli\u003eDiscuss the forms of dialysis used in hospitalized patients.\u003c\/li\u003e\r\n \t\u003cli\u003eReview the management of hyperkalemia.\u003c\/li\u003e\r\n \t\u003cli\u003eDiscuss the management of fluid overload in patients with advanced kidney disease.\u003c\/li\u003e\r\n \t\u003cli\u003eReview best practice strategies for the use of diuretics in hospitalized patient\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eUpdate in GI Inpatient Medicine\u003c\/strong\u003e\r\n\r\nAttendees of this presentation will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eEvaluate and manage both upper and lower gastrointestinal bleeding according to the current standard of care.\u003c\/li\u003e\r\n \t\u003cli\u003eManage common intestinal complications like small bowel obstruction and both minor and major constipation syndromes.\u003c\/li\u003e\r\n \t\u003cli\u003eManage common gallbladder syndromes as well as acute pancreatitis.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate and manage both appendicitis and diverticulitis.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess and strategize the common intestinal emergencies of bowel perforation and ischemia syndromes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eSeptic Arthritis\u003c\/strong\u003e\r\n\r\nAttendees of this presentation will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDetermine the risk factors associated with septic arthritis.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize the British Society of Rheumatology Guidelines for management of the hot swollen joint in adults to differentiate septic arthritis from other causes of acute monoarticular\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize epidemiological and clinical clues to determine bacterial etiology in patients with septic arthritis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eRheumatology Procedures\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eUse techniques for appropriate indications for intra-articular and soft tissue injections in rheumatology\u003c\/li\u003e\r\n \t\u003cli\u003eEmploy appropriate pharmacologic and non-pharmacologic therapies including injections for painful joints as per the ACR recommendations.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cstrong\u003eDay 4\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cstrong\u003eCrystal Arthropathies\u003c\/strong\u003e\r\n\r\nAttendees of this presentation will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDistinguish the clinical presentations and manifestations of gout and associated medical comorbidities\u003c\/li\u003e\r\n \t\u003cli\u003ePrescribe treatment for patients with gout according to the EULAR and ACR recommendations and guidelines\u003c\/li\u003e\r\n \t\u003cli\u003eDistinguish the clinical presentations, manifestations, and treatment of calcium pyrophosphate deposition disease (CPPD) and pseudogout\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eVasculitis\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eUtilize the classification of vasculitis.\u003c\/li\u003e\r\n \t\u003cli\u003eSpecify the diagnosis of specific vasculitides based on clinical, laboratory, and pathologic features.\u003c\/li\u003e\r\n \t\u003cli\u003ePrescribe treatment for patients with vasculitis based on their diagnosis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eUpdate on the Management of Stroke and Transient Ischemic Attack\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eAssess common presentations of cerebrovascular insufficiency.\u003c\/li\u003e\r\n \t\u003cli\u003ePrescribe the initial management of patients with a suspected acute CVA.\u003c\/li\u003e\r\n \t\u003cli\u003eApply cutting edge strategies and therapies for the management of hemorrhagic and thrombotic strokes.\u003c\/li\u003e\r\n \t\u003cli\u003eDistinguish between stroke and TIA and appropriately assess the patient with TIA for early risk of stroke.\u003c\/li\u003e\r\n \t\u003cli\u003eFormulate an effective post-stroke secondary prevention plan as per the AHA\/ASA guidelines.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eThe Evaluation and Management of Syncope and Vertigo\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eAppropriately evaluate patients with syncope or vertigo.\u003c\/li\u003e\r\n \t\u003cli\u003eFormulate a diagnostic evaluation strategy of syncope or vertigo that is based on best practices and the 2017 ACC\/AHA\/HRS guidelines.\u003c\/li\u003e\r\n \t\u003cli\u003eDebate the value of the various diagnostic approaches to the workup of syncope.\u003c\/li\u003e\r\n \t\u003cli\u003ePrescribe an effective therapeutic strategy for the management of both syncope and vertigo per the 2017 ACC\/AHA\/HRS guidelines.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eDelirium, Dementia, \u0026amp; Psychosis – The Diagnosis \u0026amp; Mgmt of the Inpatient with Mental Status Change\u003c\/strong\u003e\r\n\r\nAttendees of this presentation should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eApply a diagnostic approach to the hospitalized patient with acute mental status change.\u003c\/li\u003e\r\n \t\u003cli\u003eDiscuss the differential diagnosis of psychosis in the hospitalized patient.\u003c\/li\u003e\r\n \t\u003cli\u003eBased on a systematic review of the best evidence, formulate an evidence-based management strategy for delirium in the hospital setting.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop an evidence-based screening and treatment protocol for the prevention and management of alcohol withdrawal syndromes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954677485666,"sku":"MED-AMB08007","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/AMS-Hospital-and-Internal-Medicine-A-Clinical-Review-of-Common-Problems-2024.jpg?v=1779382246","url":"https:\/\/meducourse.com\/products\/ams-hospital-and-internal-medicine-a-clinical-review-of-common-problems-2024","provider":"Meducourse","version":"1.0","type":"link"}